In vitro chemosensitivity testing of primary and recurrent breast carcinomas and its clinical significance

Zhi Li , Haiping Song , Wenshan He , Yuan Tian , Tao Huang

Current Medical Science ›› 2008, Vol. 28 ›› Issue (16) : 683 -687.

PDF
Current Medical Science ›› 2008, Vol. 28 ›› Issue (16) : 683 -687. DOI: 10.1007/s11596-008-0616-5
Article

In vitro chemosensitivity testing of primary and recurrent breast carcinomas and its clinical significance

Author information +
History +
PDF

Abstract

In this study, in vitro chemosensitivity testing was conducted on primary cultured breast cancer cells from 96 patients with breast cancer, and the results showed that the cells from a few patients with primary breast cancer developed multidrug resistance (MDR) prior to the first chemotherapy exposure. All the cells from the recurrent cancer patients had MDR. The findings suggested that patients having MDR would benefit from high-dose chemotherapy (HDC) regimens. In vitro chemosensitivity screening, which was aimed at improving the therapeutic efficacy and minimizing side effects, helps in choosing individualized treatment for breast cancer.

Keywords

chemotherapy / breast cancer / primary culture / in vitro study

Cite this article

Download citation ▾
Zhi Li, Haiping Song, Wenshan He, Yuan Tian, Tao Huang. In vitro chemosensitivity testing of primary and recurrent breast carcinomas and its clinical significance. Current Medical Science, 2008, 28(16): 683-687 DOI:10.1007/s11596-008-0616-5

登录浏览全文

4963

注册一个新账户 忘记密码

References

AI Summary AI Mindmap
PDF

62

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/